Sort by:
2532 products
2532 products
PREMARIN Vaginal Cream 43 g
Comparable to: Premarin
Active ingredient: Conjugated estrogens
Presentation: Tube with 43 g of vaginal cream
Laboratory: Wyeth
Origin: Mexico
This medication is used for the treatment of vaginal symptoms associated with menopause, such as dryness, itching, and pain during sexual intercourse. Conjugated estrogens help restore the vaginal mucosa and improve tissue lubrication and elasticity.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
Contraindications: Suspected or confirmed pregnancy (see Restrictions of use during pregnancy and lactation).
Undiagnosed abnormal bleeding.
Suspected or confirmed estrogen-dependent neoplasia (eg endometrial cancer, endometrial hyperplasia).
History of active arterial thromboembolic disease (eg stroke, myocardial infarction) or deep thromboembolism (such as deep vein thrombosis, pulmonary embolism).
Dysfunction or active liver disease or chronic.
Known or suspected hypersensitivity to ingredients.
GENERAL PRECAUTIONS: Systemic absorption can occur with the use of vaginal cream with ECE. It must take into account the precautions and warnings associated with the oral treatment of ECE.
Fluid retention: Since estrogen / progestin may cause a degree of fluid retention in patients with conditions that can be influenced by this factor, such as cardiac or renal dysfunction, ensure careful observation when estrogens are prescribed.
In the study of health and osteoporosis, progestin and estrogen (HOPE), the mean increases from baseline in serum triglycerides after one year of treatment with CEE 0.625, 0.45 and 0.3 mg compared with placebo were 34.3,30.2 , 25.1, and 10.7 respectively.
Impaired liver function: Patients with impaired liver function may metabolize poorly estrogen / progestin.
History of cholestatic jaundice: For patients with a history of cholestatic jaundice associated with past use of estrogen or pregnancy, caution should be exercised, and in case of recurrence, medication should be discontinued.
You must select the lowest dose that controls your symptoms and should be discontinued ifsymptoms persist.
Usual dose range: ½ to two grams a day, vaginally, depending on the severity of the condition. Ensure that the discontinuation or reduction of medication takes place at intervals of 3 to 6 months.
Concomitant progestogen: The addition of a progestin during the administration of estrogenreduces the risk of endometrial hyperplasia and carcinoma, which has been associated withlong-term use of unopposed estrogen.
Morphological and biochemical studies of endometrium suggest that you need to manage for 10 to 14 days to provide maximum maturation of the endometrium in order to eliminate anyhyperplastic alteration.
Since progestogens are administered to protect against endometrial hyperplastic changes, patients without a uterus may not need a progestin. Administration should be cyclic (eg, three weeks of treatment and rest) and only for short-term therapy.
Patients should be reevaluated periodically to determine whether treatment of the symptomsis still necessary.
PROVERA (MEDROXYPROGESTERONE)
Comparable to: Provera
Active ingredient: Medroxyprogesterone
Concentration: 5 mg
Presentation: Box with 24 tablets
Laboratory: PFIZER
Origin: Mexico
Provera is a hormonal medication indicated for the treatment of various gynecological disorders, such as menstrual cycle irregularities, secondary amenorrhea, dysfunctional uterine bleeding, and as part of hormone therapies. It works by regulating hormonal balance and promoting normal endometrial function.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
PROGYLUTON (ESTRADIOL / NORGESTREL)
Comparable to: Progyluton
Active substance: Estradiol / Norgestrel
Presentation: Box with 21 dragees
Laboratory: Bayer de Mexico
Origin: Mexico
Progyluton is a hormonal medication primarily used to regulate the menstrual cycle and as part of hormone therapies for gynecological disorders. The combination of estradiol and norgestrel acts on the endocrine system, helping to balance female hormone levels.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
PREMARIN (CONJUGATED ESTROGENS)
Comparable to: Premarin
Active ingredient: Conjugated estrogens
Concentration: 0.625 mg
Presentation: Box with 42 tablets
Manufacturer: Wyeth
Origin: Mexico
Premarin is a hormonal medication indicated for the treatment of symptoms associated with menopause, such as hot flashes, night sweats, and vaginal changes. It can also be used in hormone replacement therapies and in certain gynecological disorders, helping to restore hormonal balance.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
MACRODANTIN (NITROFURANTOIN) 50 mg
Comparable to: Macrodantin
Active ingredient: Nitrofurantoin
Concentration: 50 mg per capsule
Presentation: Box with 40 capsules
Manufacturer: Boehringer
Origin: Mexico
This medication is used for the treatment and prevention of urinary tract infections caused by bacteria sensitive to nitrofurantoin. It works by eliminating the bacteria responsible for the infection in the urinary tract.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
Prescription required.
BACTRIM F (SULFAMETHOXAZOLE / TRIMETHOPRIM) 160 mg / 800 mg
Comparable to: Bactrim F
Active ingredient: Sulfamethoxazole / Trimethoprim
Concentration: 160 mg / 800 mg per tablet
Presentation: Box with 15 tablets
Laboratory: Waserpharma, S. A. DE CV
Origin: Mexico
This medication is used for the treatment of various bacterial infections, such as urinary tract, respiratory, gastrointestinal infections, and others caused by susceptible microorganisms. The combination of sulfamethoxazole and trimethoprim works by inhibiting folate synthesis in bacteria, which prevents their growth and reproduction.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Prescription required for sale.
EUTIROX (LEVOTHYROXINE SODIUM) 25 mcg
Comparable to: Eutirox
Active ingredient: Levothyroxine sodium
Concentration: 25 mcg per tablet
Presentation: Box with 50 tablets
Laboratory: Merck
Origin: Mexico
This medication is used for the treatment of hypothyroidism, helping to normalize thyroid hormone levels and regulate the body's metabolism, promoting energy balance and various physiological functions.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
PROPESHIA (FINASTERIDE)
Comparable to: Propecia
Active ingredient: Finasteride
Concentration: 1 mg
Presentation: Box with 28 coated tablets
Laboratory: Merck
Origin: Mexico
Propeshia is a medication indicated for the treatment of androgenetic alopecia (male pattern hair loss). It works by inhibiting the conversion of testosterone into dihydrotestosterone (DHT), helping to reduce hair loss and promoting its preservation.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
NEXIUN-MUPS (ESOMEPRAZOLE) 40 mg
Comparable to: Nexium
Active ingredient: Esomeprazole
Concentration: 40 mg per tablet
Presentation: Box with 14 MUPS tablets
Laboratory: AstraZeneca
Origin: Mexico
This medication is used for the treatment of diseases related to excess stomach acid, such as gastroesophageal reflux, erosive esophagitis, and gastric or duodenal ulcers, helping to reduce acid production and relieve symptoms such as heartburn, pain, and stomach burning.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
MOTILIUM (DOMPERIDONE) 10 mg
Comparable to: Motilium
Active ingredient: Domperidone
Concentration: 10 mg per tablet
Presentation: Box with 30 tablets
Laboratory: JANSSEN-CILAG
Origin: Mexico
This medicine is used for the treatment of nausea, vomiting, and symptoms of slow gastrointestinal motility (such as feeling of fullness, bloating, and post-prandial discomfort). Domperidone works by increasing stomach and intestinal movement, facilitating digestion and reducing nausea.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
- Feeling at epigastric fullness, early satiety, feeling of abdominal distention, upper abdominal pain.
- Belching, flatulence.
- Nausea and vomiting.
- Heartburn with or without regurgitation of gastric contents into the mouth.
- Nausea and vomiting of functional origin, organic, infectious or dietetic or induced by radiation therapy or pharmacotherapy.
A specific indication is nausea and vomiting induced by dopamine agonists, such as those used in Parkinson's disease (such as L-dopa and bromocriptine).
CONTRAINDICATIONS: Motilium ® is contraindicated in the following situations:
Known hypersensitivity to domperidone or any of its excipients.
Prolactin-releasing pituitary tumor (prolactinoma).
Coadministration with oral ketoconazole, erythromycin, or other potent CYP3A4 inhibitors that prolong the QTc interval such as fluconazole, voriconazole, clarithromycin, amiodarone, and telithromycin.
Motilium ® should not be used in cases in which the stimulation of gastric motility might be dangerous, for example, gastrointestinal hemorrhage, mechanical obstruction or perforation.
CAUTIONS: When using antacids or antisecretory agents, concomitantly, they should be administered after meals and not before them, ie should not be administered simultaneously with the tablets and suspension Motilium ®.
Use Precautions: Enteric coated tablets contain lactose and may be unsuitable for patients with lactose intolerance, galactosemia, or malabsorption of glucose / galactose.
The oral suspension contains sorbitol and may be inadequate for patients intolerant to sorbitol.
Use in children: Because the metabolic and blood-brain barrier are not fully developed during the first months of life, Motilium ® as well as any medication that is administered to infants younger, should be used with caution and under close supervision care.
Since the typical absence of neurological side effects Motilium ® is due to the limited penetration through the blood brain barrier, the occurrence of these effects can not be totally excluded in babies under 1 year.
Use in hepatic impairment: Since domperidone is extensively metabolized in the liver, Motilium ® should be used with caution in patients with liver damage.
Use in renal impairment: In patients with severe renal insufficiency (serum creatinine> 6 mg/100 ml, for example,> 0.6 mmol / l) elimination half-life of domperidone is increased from 7.4 to 20.8 hours but plasma levels are lower than in healthy volunteers. Since a small amount of the drug is excreted by the kidneys, it is unlikely that the dose of a single acute dose needs to be adjusted in patients with renal failure. However, with repeated administration, frequency of administration should be reduced to once or twice daily depending on the severity of damage, and may also be necessary to reduce the dose.
Generally, patients with prolonged therapy should be reviewed regularly.
Effects on ability or use machines: Motilium ® does not affect mental alertness.
RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION:
Use in pregnancy: There are limited post-marketing data on the use of domperidone in pregnant women. A study in rats has shown reproductive toxicity at high doses, is toxic to the mother. No one knows the potential risk to humans. Therefore, Motilium ® should be used during pregnancy only where justified by the anticipated therapeutic benefit.
Adults and adolescents (over 12 years and weighing 35 kg or more):
Tablets: 1 to 2 tablets of 10 mg three to four times a day, with a maximum daily dose of 80 mg.
CARNOTPRIM (METOCLOPRAMIDE) 10 mg
Comparable to: Carnotprim
Active substance: Metoclopramide
Concentration: 10 mg per tablet
Presentation: Box with 20 tablets
Laboratory: Carnot
Origin: Mexico
This medication is used for the treatment of nausea and vomiting of various causes, as well as in the management of gastrointestinal motility disorders, as metoclopramide helps to accelerate stomach emptying and promotes intestinal movement.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
Gastrointestinal Disorders: gastroesophageal reflux, infectious gastroenteritis, gastric ulcer, pyloric stenosis, chronic primitive intestinal pseudo-obstructions.
Iatrogenic gastroparesis: To counteract the effects of the use of anticholinergics, opiates, dopaminergics.
Surgical sequelae: Vagotomy with pyloroplasty, fundic vagotomy, partial gastrectomies.
Psychic and neuromuscular disorders: Anorexia nervosa, amyloidosis, collagenopathies, scleroderma, muscular dystrophies (spastic colon), various neuropsychiatric syndromes.
Metabolic and endocrine disorders: diabetes, hypothyroidism, renal failure.
In acute or chronic vomiting, of gastroenterological, infectious, metabolic, endocrine, neurological, iatrogenic, psychogenic, anatomical, respiratory etiology.
Prophylactic utility in nausea and/or vomiting caused by: Chemotherapy, radiotherapy, perianesthesia, motion sickness, etc.
Of analgesic utility due to central action (alone or in interaction): As an aid in headaches of vascular origin (migraine).
Useful in the induction of lactation. An aid when lactation needs to be induced.
CONTRAINDICATIONS: Hypersensitivity to metoclopramide. Intestinal obstruction, perforation, or any other condition in which increased gastrointestinal motility is risky. Acute appendicitis, extrapyramidal syndrome.
GENERAL PRECAUTIONS: When metoclopramide is administered concomitantly with psychotropics, antihistamines, or barbiturates, it should be noted that it may produce additional depressive effects on the CNS, likewise when alcohol is consumed concomitantly with the medication.
When the parenteral route is used, if the medication is administered rapidly, extrapyramidal symptoms (torticollis, trismus, oculogyric crises) may occur, which are reversible upon discontinuation of the medication or subside with the administration of diazepam or diphenhydramine. In international literature, the appearance of extrapyramidal symptoms with the administration of metoclopramide at therapeutic doses is 1 in 33,000 patients.
In patients with chronic renal failure, the administration of the drug for prolonged periods should be evaluated, because its elimination is renal in 98% of cases, and if necessary, the dose of the medication will be adjusted.
RESTRICTIONS ON USE DURING PREGNANCY AND LACTATION: Metoclopramide has been widely used during pregnancy to relieve hyperemesis gravidarum, gastroesophageal reflux, and gastroparesis that may occur during pregnancy.
The general consensus recommends its use during the second and third trimesters of pregnancy, and as with the vast majority of medications not contraindicated during pregnancy, its prescription during the first trimester is left to the discretion of the treating physician, taking into account the severity of the case, the potential benefits and the probable risk that there might be for the product.
Metoclopramide is eliminated in small doses in breast milk (see Dosage and Administration).
CARNOTPRIM Tablets 10 mg: (gastroprokinetic, antiemetic, gastroesophageal reflux, anti-migraine).
Children 6 to 12 years: ½ tablet (5 mg) 3 times daily before meals.
Over 12 years or over 40 kg:
1 tablet 3 or 4 times daily before meals.
CARNOTPRIM Tablets 10 mg: (gastroprokinetic, antiemetic, anti-migraine, assist in the induction of lactation).
Adults and children over 40 kg: 1 tablet 3 or 4 times daily before meals.
Induction of lactation: 1 tablet every 8 hours, depending on the response of the patient, for a maximum period of 10 days.
TERRAMYCIN Ophthalmic Ointment 10 g
Comparable to: Terramycin
Active ingredient: Oxytetracycline
Presentation: Tube with 10 g of ophthalmic ointment
Laboratory: PFIZER
Origin: Mexico
This ophthalmic ointment is used for the treatment and prevention of bacterial infections of the ocular surface and eyelids caused by susceptible microorganisms. Oxytetracycline works by inhibiting bacterial growth, helping to control the infection and relieve symptoms such as redness, discharge, or ocular discomfort.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
GAAP (LATANOPROST) 0.005% Ophthalmic Solution 3 mL
Comparable to: Xalatan
Active ingredient: Latanoprost
Concentration: 0.005%
Presentation: Bottle with 3 mL of ophthalmic solution
Laboratory: Sophia
Origin: Mexico
This ophthalmic medication is used for the treatment of open-angle glaucoma and ocular hypertension. Latanoprost is a prostaglandin analog that works by increasing the outflow of aqueous humor, helping to lower intraocular pressure and prevent damage to the optic nerve associated with these conditions.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
Prescription required for sale.
Hypersensitivity to the components of the formula.
CAUTIONS: Latanoprost should be used with caution in patients with a history of intraocular inflammationand should be avoided in patients with active intraocular inflammation.
Patients with aphakia or Pseudophakia.
Patients with risk factors for developing macular edema.
For contact lens wearers, we recommend GAAP OFTEN ® instilled 20 minutes before placement.
Avoid contamination we recommend avoiding contact with the tip of the dropper bottle.
DOSAGE AND ADMINISTRATION: Ophthalmic.
Apply 1 drop of GAAP OFTEN ® in the lower conjunctival fornix every 24 hours. It recommends the evening.
ALPHAGAN (BRIMONIDINE) 0.02% Ophthalmic Solution
Comparable to: Alphagan
Active ingredient: Brimonidine
Concentration: 0.02%
Presentation: Ophthalmic solution
Laboratory: Allergan
Origin: Mexico
This ophthalmic medication is used for the treatment of open-angle glaucoma and ocular hypertension. Brimonidine works by reducing the production of aqueous humor and increasing its outflow, helping to lower intraocular pressure and protect the optic nerve.
The consumption of this product is the responsibility of whoever recommends and whoever uses it. Consult your doctor before consuming any medication.
Prescription required for sale.
Related Products
- Choosing a selection results in a full page refresh.
- Opens in a new window.